Femasys is trading 10.9% down now at $2.37 as investors continue reacting negatively to the $30 million private placement announced August 7, 2026.

  • Financing includes 9,374,999 shares or pre-funded warrants and warrants covering 18,749,998 additional shares, creating substantial potential dilution.
  • Accompanying warrants carry a $2.95 exercise price; closing is expected around August 10, 2026.
  • Shares fell 9.83% on August 7, 2026, while broader markets were only modestly lower, making company-specific financing the clearest catalyst.